eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
3.380
-0.050 (-1.46%)
At close: Nov 19, 2026, 4:00 PM EST
3.330
-0.050 (-1.48%)
After-hours: Nov 19, 2026, 7:30 PM EST
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $31.37 million as of November 19, 2026. It is the 33,064th most valuable company in the world and the 4,826th biggest in the United States. Its market cap has decreased by 74.24% in one year.
Market Cap
31.37M
Enterprise Value
29.11M
1-Year Change
-74.24%
Global Rank
Country Rank
#4,826 United States
Category
ChartMarket Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $31.37M, a decrease of -55.38%. That is a compound annual growth rate of -32.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 31.37M | -65.69% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 34.69M |
| Kalaris Therapeutics | 34.52M |
| CEL-SCI | 34.21M |
| Serina Therapeutics | 34.04M |
| Telomir Pharmaceuticals | 32.85M |
| NextCure | 32.52M |
| Alterity Therapeutics | 31.98M |
| BriaCell Therapeutics | 30.35M |